Swiss National Bank Trims Stock Position in Amedisys, Inc. $AMED

Swiss National Bank reduced its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 1.4% during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 63,500 shares of the health services provider’s stock after selling 900 shares during the quarter. Swiss National Bank owned approximately 0.19% of Amedisys worth $5,882,000 at the end of the most recent reporting period.

Other hedge funds have also added to or reduced their stakes in the company. Pentwater Capital Management LP boosted its holdings in shares of Amedisys by 178.3% during the 4th quarter. Pentwater Capital Management LP now owns 1,180,000 shares of the health services provider’s stock valued at $107,132,000 after acquiring an additional 756,000 shares during the last quarter. Alpine Associates Management Inc. boosted its holdings in shares of Amedisys by 11.7% during the 1st quarter. Alpine Associates Management Inc. now owns 992,120 shares of the health services provider’s stock valued at $91,900,000 after acquiring an additional 104,000 shares during the last quarter. AQR Arbitrage LLC boosted its holdings in shares of Amedisys by 59.1% during the 4th quarter. AQR Arbitrage LLC now owns 471,965 shares of the health services provider’s stock valued at $42,812,000 after acquiring an additional 175,311 shares during the last quarter. Adage Capital Partners GP L.L.C. boosted its holdings in shares of Amedisys by 32.3% during the 4th quarter. Adage Capital Partners GP L.L.C. now owns 418,002 shares of the health services provider’s stock valued at $37,950,000 after acquiring an additional 102,099 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in shares of Amedisys by 0.4% during the 1st quarter. Charles Schwab Investment Management Inc. now owns 363,291 shares of the health services provider’s stock valued at $33,652,000 after acquiring an additional 1,479 shares during the last quarter. 94.36% of the stock is owned by hedge funds and other institutional investors.

Amedisys Price Performance

AMED stock opened at $101.01 on Tuesday. The business has a 50 day moving average price of $98.15 and a 200 day moving average price of $94.82. The stock has a market cap of $3.32 billion, a price-to-earnings ratio of 39.30, a PEG ratio of 1.34 and a beta of 0.89. Amedisys, Inc. has a fifty-two week low of $82.15 and a fifty-two week high of $101.02. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.26.

Amedisys (NASDAQ:AMED) last released its earnings results on Tuesday, July 29th. The health services provider reported $1.54 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.15. The business had revenue of $621.86 million for the quarter, compared to analyst estimates of $614.61 million. Amedisys had a return on equity of 12.91% and a net margin of 3.56%. The company’s revenue for the quarter was up 5.2% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.98 earnings per share. Equities research analysts anticipate that Amedisys, Inc. will post 4.4 earnings per share for the current fiscal year.

Analyst Ratings Changes

Separately, Wall Street Zen lowered shares of Amedisys from a “strong-buy” rating to a “buy” rating in a report on Saturday, May 24th.

Amedisys Company Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.